Skip to main content
Log in

AAV-FIX-Padua gene therapy cost effective for severe haemophilia B

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Bolous NS, et al. The Cost-effectiveness of Gene Therapy for Severe Hemophilia B: Microsimulation Study from the United States Perspective. Blood : 25 Apr 2021. Available from: URL: http://doi.org/10.1182/blood.2021010864

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

AAV-FIX-Padua gene therapy cost effective for severe haemophilia B. PharmacoEcon Outcomes News 878, 1 (2021). https://doi.org/10.1007/s40274-021-7687-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7687-y

Navigation